Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 8:14 pm Purchase | 13G | Inhibrx Biosciences Inc. INBX | PERCEPTIVE ADVISORS LLC | 1,488,553 9.900% | 1,488,553 (New Position) | View |
| 2024-06-07 4:23 pm Purchase | 13G | Inhibrx Biosciences Inc. INBX | VIKING GLOBAL INVESTORS LP | 1,787,705 12.300% | 1,787,705 (New Position) | View |
| 2024-06-03 8:45 pm Purchase | 13D | Inhibrx Biosciences Inc. INBX | Kayyem Jon Faiz | 818,575 5.650% | 818,575 (New Position) | View |
| 2024-06-03 8:43 pm Purchase | 13D | Inhibrx Biosciences Inc. INBX | Lappe Mark | 761,413 5.260% | 761,413 (New Position) | View |
| 2024-05-31 4:30 pm Purchase | 13G | Inhibrx Biosciences Inc. INBX | Sanofi SNY | 1,157,926 8.000% | 1,157,926 (New Position) | View |